Controversies in Neonatal Seizure Management
Authors:
- 13 February 2009
- journal article
- review article
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 24 (5) , 591-599
Abstract
Seizures in the newborn period are common and frequently indicate serious underlying brain injury. Although accumulating evidence suggests that they may impair brain development, there are currently no evidence-based guidelines for evaluation and management of neonatal seizures. In this review, we will address some of the current controversies facing child neurologists and neonatologists, including how to define, monitor, and treat neonatal seizures.Keywords
This publication has 102 references indexed in Scilit:
- Improving the Treatment of Neonatal Seizures: National Institute of Neurological Disorders and Stroke Workshop ReportThe Journal of Pediatrics, 2008
- Neonatal Seizures: Dilemmas in Workup and ManagementPediatric Neurology, 2008
- Treatments with midazolam and lidocaine for status epilepticus in neonatesBrain and Development, 2007
- The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- Neuropathology of seizures in the immature rabbitDevelopmental Brain Research, 2004
- Recurrent seizures in immature rats: effect on auditory and visual discriminationDevelopmental Brain Research, 1996
- GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesisNeuron, 1995
- Seizures, brain damage and brain developmentBrain and Development, 1994
- Kainic acid seizures in the developing brain: status epilepticus and spontaneous recurrent seizuresDevelopmental Brain Research, 1992
- Phenobarbital for Febrile Seizures — Effects on Intelligence and on Seizure RecurrenceNew England Journal of Medicine, 1990